The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) will be reporting earnings tomorrow morning. Here’s what to look ...

Pfizer faces stagnant revenue and patent cliffs. Learn why I downgraded PFE stock to Strong Sell despite a 24.7% YoY growth ...

System1, the creative effectiveness platform, has revealed consumers’ favourite ads from the 2025 Super Bowl: Lay’s, the NFL, ...

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

The 67th running of the Daytona 500, the Great American Race arrives Sunday at Daytona International Speedway.

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...

O n what seemed like a normal day in 2004, LL COOL J’s wife Simone I. Smith, then in her 30s, was working out with her ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

In mid-2024, the commercial president of Pfizer’s oncology unit Suneet Varma announced his retirement after 15 years with the ...